Primary care practitioners serve a critical role in optimizing clinical outcomes for adults with type 2 diabetes.
GLP-1 medications like Ozempic and Wegovy are used for weight loss and diabetes. Learn how they work, their costs, and potential side effects.
Research found that the weight-loss medications may reduce the spread of several obesity-related cancers, including lung, ...
Glucagon-like peptide-1 receptor agonists vs alternative therapies are not associated with increased risk for suicide and may lower risk.
GLP-1 drugs commonly used for weight loss and diabetes decreased the risk of cancer spreading in patients with several ...
9don MSN
GLP-1 Weight Loss Drugs May Reduce the Chance of Certain Cancers Progressing, New Study Suggests
GLP-1 medications were initially developed and prescribed to help manage blood sugar in people with Type 2 diabetes ...
GLP-1S HAVE BEEN called “wonder drugs” for how they have revolutionized weight loss, and they’re being explored for their potential in helping with other health conditions. For all of the positive ...
Initiation of GLP-1 drugs was associated with a 14% lower risk of developing new substance use disorders compared with SGLT2 inhibitors in veterans. Veterans with pre-existing substance use disorders ...
GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week ...
Real-world data show that GLP-1 receptor agonists (GLP-1s) may reduce metastatic progression of certain obesity-related ...
Please provide your email address to receive an email when new articles are posted on . SGLT2 inhibitors were linked to lower risks for CKD and AKI but greater risks for albuminuria vs. GLP-1s. Risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results